72 related articles for article (PubMed ID: 3003470)
21. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I
IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625
[TBL] [Abstract][Full Text] [Related]
22. Histocompatibility antigens in patients with hepatocellular carcinoma.
Golubovic G; Stajic M; Stolic I; Nikolic JA; Neskovic AN; Pandey L
Z Gastroenterol; 1996 Jan; 34(1):15-20. PubMed ID: 8776170
[TBL] [Abstract][Full Text] [Related]
23. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.
Jee SH; Ohrr H; Sull JW; Samet JM
J Natl Cancer Inst; 2004 Dec; 96(24):1851-6. PubMed ID: 15601641
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B surface antigen and alpha-1-fetoprotein in hepatoma. Reports of 157 cases.
Pongpipat D; Suvatte V; Plengvanit U; Chinapak O; Bunyaphisit S; Assateerawatts A
J Med Assoc Thai; 1983 Nov; 66(11):696-9. PubMed ID: 6200559
[No Abstract] [Full Text] [Related]
25. Primary hepatic carcinoma. Its incidence and relationship to HBsAg.
Sandlow LJ; Spellberg MA
Am J Gastroenterol; 1980 Dec; 74(6):512-5. PubMed ID: 6259934
[TBL] [Abstract][Full Text] [Related]
26. [Epidemiological analysis of the etiological relationship between primary hepatocarcinoma and hepatitis B virus].
Ding ZR
Zhonghua Liu Xing Bing Xue Za Zhi; 1984 Jun; 5(3):146-9. PubMed ID: 6097361
[No Abstract] [Full Text] [Related]
27. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine.
Sun TT; Chu YR; Ni ZQ; Lu JH; Huang F; Ni ZP; Pei XF; Yu ZI; Liu GT
J Cell Physiol Suppl; 1986; 4():83-90. PubMed ID: 3018008
[TBL] [Abstract][Full Text] [Related]
28. Effect of cytotoxic chemotherapy on hepatitis B viral markers in patients with hepatocellular carcinoma.
Zaman S; Melia W; Johnson P; White Y; Williams R
Clin Oncol; 1984 Sep; 10(3):247-52. PubMed ID: 6090048
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
30. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
31. [Management of the chronic carrier of hepatitis B surface antigen (HBsAg)].
Ramalho F
Acta Med Port; 1983; 4(11-12):501-8. PubMed ID: 6198872
[No Abstract] [Full Text] [Related]
32. Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin.
Johnson PJ; Wansbrough-Jones MH; Portmann B; Eddleston AL; Williams R; Maycook WD; Calne RY
Br Med J; 1978 Jan; 1(6107):216. PubMed ID: 202371
[No Abstract] [Full Text] [Related]
33. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.
Wang CS; Yao WJ; Chang TT; Wang ST; Chou P
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2054-60. PubMed ID: 19549812
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13676 relatives with hepatocellular carcinoma.
Chen CH; Chen YY; Chen GH; Yang SS; Tang HS; Lin HH; Lin DY; Lo SK; Du JM; Chang TT; Chen SC; Liao LY; Kuo CH; Lin KC; Tai DI; Changchien CS; Chang WY; Sheu JC; Chen DS; Liaw YF; Sung JL
J Hepatol; 2004 Apr; 40(4):653-9. PubMed ID: 15030982
[TBL] [Abstract][Full Text] [Related]
35. Familial active chronic hepatitis with hepatocellular carcinoma. Report of a case.
Joske RA; Laurence BH; Matz LR
Gastroenterology; 1972 Mar; 62(3):441-4. PubMed ID: 4334824
[No Abstract] [Full Text] [Related]
36. Hepatitis B surface antigen containing immune complexes occur in seronegative hepatocellular carcinoma patients.
Brown SE; Howard CR; Steward MW; Ajdukiewicz AB; Whittle HC
Clin Exp Immunol; 1984 Feb; 55(2):355-9. PubMed ID: 6199140
[TBL] [Abstract][Full Text] [Related]
37. HBV-DNA in sera of patients with HBsAg-positive primary liver cell carcinoma.
Theilmann L; Gmelin K; Will H; Czygan P; Hasche G; Doerr HW; Kommerell B
Z Gastroenterol; 1984 Apr; 22(4):182-7. PubMed ID: 6328781
[TBL] [Abstract][Full Text] [Related]
38. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
Grob PJ
Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
[TBL] [Abstract][Full Text] [Related]
39. [Morphological demonstration of hepatitis B virus surface antigen in liver cirrhosis, fibrosis and hepatocellular carcinoma (author's transl)].
Chlumská A; Kautzner J
Cas Lek Cesk; 1981 Jun; 120(23):689-92. PubMed ID: 6265089
[No Abstract] [Full Text] [Related]
40. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
